secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aptevo Therapeutics Inc. (APVO)
CIK:        0001671584
Form:       8-K
Filed at:   2025-06-17T23:59:59+00:00
Accession:  0000950170-25-087368
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aptevo Therapeutics enters $25M standby equity purchase agreement with Yorkville
--------------------------------------------------------------------------------

- Up to $25M in common stock may be sold to YA II PN over 36 months at 96% of lowest 3-day VWAP.
- Exchange cap of 151,755 shares (19.99% of outstanding) unless stockholder approval or avg price ≥ $3.66.
- Yorkville's beneficial ownership limited to 9.99% of outstanding shares.
- Structuring fee of $25,000 paid; commitment fee of 2% of commitment amount in five quarterly installments.
- Advance subject to filing and effectiveness of registration statement with the SEC.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1671584/000095017025087368/0000950170-25-087368-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1671584/000095017025087368/apvo-20250616.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-087368

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer